Biotech Values

[iwfal]

For Feuerstein to say that Satra may affect only pain and not survival is premature, IMO; I know of no MoA explanation of why this should be true. Let’s wait to see what the actual survival data show.

p.s. I have not seen the “separate analysis” that Feuerstein referred to, but I don’t think I need to.

I would submit that if the p value for death is substantially the wrong way, then the NDA is at substantial risk.

As for MOA - chemo is dangerous. It doesn't seem unreasonable to suppose that two chemo drugs together may kill patients.

Of course, having said all of that I will further state that I know nothing at all about the protocol or the drug other than that it is another platinum drug.

Clark